GlassScriptPhysician profile
Grace Maria Joseph
NPI 1992359038
$1,462.65
in general payments reported to CMS, 2019-2025
17 companies · $854 in 2025
The $854 reported for 2025 was more than what 83% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $173 · 2024: $436 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $269.46 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $189.84 | 2024-2025 | Wegovy, Ozempic |
| Amgen INC. | $176.31 | 2025 | Otezla, Repatha |
| Abbvie INC. | $172.65 | 2023-2025 | |
| Pfizer INC. | $107.24 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $91.33 | 2024-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $79.78 | 2024-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $68.84 | 2023-2024 | Trelegy Ellipta |
| Shield Therapeutics INC | $64.31 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.78 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $42.12 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Esperion Therapeutics, INC. | $40.97 | 2024 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.72 | 2024 | Xifaxan |
| Dynavax Technologies Corporation | $27.14 | 2024 | Heplisav-B |
| Si-Bone, INC. | $19.67 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $17.42 | 2025 | |
| Optinose US, INC. | $14.07 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.